2021
DOI: 10.1155/2021/8812044
|View full text |Cite
|
Sign up to set email alerts
|

Echocardiographic Features of Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy

Abstract: Background. Emery-Dreifuss muscular dystrophy (EDMD) is a very rare type of muscular dystrophy characterized by musculoskeletal abnormalities accompanied by cardiac defects. Two most common genetic subtypes are EDMD1 due to EMD and EDMD2 caused by LMNA gene mutations. The aim of the study was to characterize and compare the cardiac morphology and function in the two main genetic subgroups of EDMD with the use of echocardiography. Methods. 41 patients with EDMD (29 EDMD1 and 12 EDMD2) as well as 25 healthy cont… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 38 publications
0
11
0
Order By: Relevance
“…Depressed left ventricular systolic function is a typical feature of cardiomyopathy in the course of dystrophinopathy [29] and laminopathy [22]. There is also evidence of both ventricles' involvement in cardiomyopathy when EDMD is diagnosed [3]. Interestingly, in our cohort, LVSF (left ventricular ejection fraction [LVEF]) as a left ventricular function parameter differed between those patients developing events and those who did not present events.…”
mentioning
confidence: 60%
See 2 more Smart Citations
“…Depressed left ventricular systolic function is a typical feature of cardiomyopathy in the course of dystrophinopathy [29] and laminopathy [22]. There is also evidence of both ventricles' involvement in cardiomyopathy when EDMD is diagnosed [3]. Interestingly, in our cohort, LVSF (left ventricular ejection fraction [LVEF]) as a left ventricular function parameter differed between those patients developing events and those who did not present events.…”
mentioning
confidence: 60%
“…At inclusion, the transthoracic echocardiography was performed in all subjects. All four heart chambers diameters and volumes, as well as the systolic function of both right and left ventricles, were measured according to the protocol previously described [3]. Venous blood samples were obtained at inclusion, and plasma levels of cardiac biomarkers (NT-proBNP, Roche Diagnostics GmbH, Mannheim, Germany; NT-proANP, Biomedica Medizinpro-dukte® GmbH, Wien, Austria) were determined.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Cardiac involvement in EDMD2 is more variable and more difficult to predict than in EDMD1, being associated with earlier and more aggressive course, culminating in a dilated (sometimes restrictive) cardiomyopathy with decreased LVEF. 2 , 4 , 7 Neurohormonal modulation therapy constitutes the main treatment of left ventricular dysfunction, although specific data on the efficacy of this therapy in EDMD is lacking. 3 , 8 Heart transplantation constitutes an option for end-stage HF, if muscular symptoms are not severe and incapacitating.…”
Section: Discussionmentioning
confidence: 99%
“…EDMD is a rare disease characterized by a high frequency of cardiac involvement that usually presents as supraventricular and ventricular arrhythmias, conduction disorders, chamber dilation, and systolic dysfunction. 1,2,16,24,25 The most common echocardiographic findings in EDMD patients characterize the DCM phenotype and include LV dilatation and systolic dysfunction, LV diastolic dysfunction, and bi-atrial enlargement. Atrial standstill and an increased risk of embolic phenomena may also occur.…”
Section: Cardiac Presentation and Echocardiographic Findings In Edmdmentioning
confidence: 99%